Effect of Muscular Relaxation and Breathing Technique on Blood Pressure in Pregnancy
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Gestational hypertension is the main cause of maternal and fetal mortality, however, it has no definite effective treatment. nowadays, the stress management approaches are use for essential hypertension. So, this study aimed is study the effect of progressive muscular relaxation and breathing control technique on blood pressure during pregnancy. this 3-groups clinical trial has been done in Mashhad Health Centers and Governmental hospitals. 60 pregnant women with systolic blood pressure less than 135 mm Hg or diastolic blood pressure more than 85 mm Hg who met inclusion criteria were assigned into three groups of progressive muscular relaxation, breathing control and control. In tow experiment groups, exercises were controlled by one day personally and the rest by CD, BP before and after interventions was controlled for 4 weeks. In control group blood pressure was measured before and after 15 minutes with no intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Feb 2010
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 24, 2012
CompletedFirst Posted
Study publicly available on registry
August 15, 2012
CompletedAugust 16, 2012
August 1, 2012
1.6 years
July 24, 2012
August 15, 2012
Conditions
Outcome Measures
Primary Outcomes (2)
effect of muscular relaxation
effect of muscular relaxation by check of the blood pressure after muscular relaxation was controlled
up to1 month
decrease blood pressure
up to 1 month
Secondary Outcomes (1)
time of decreasing blood pressure
up to 1 month
Study Arms (3)
muscular relaxation
EXPERIMENTALmuscular relaxation was done using Jacobson by contracting and relaxing selected groups of muscles until total relaxation
breath control
EXPERIMENTALinclude deep diaphragmatic breathing and decrease breath rate to 6-10/min
control
OTHERreceived routine care of clinic or health center and control their blood pressure weekly and use drugs if necessary
Interventions
muscular relaxation was done using Jacobson by contracting and relaxing selected groups of muscles until total relaxation
breathing control techniques include deep diaphragmatic breathing and decrease breath rate to 6-10/min
received routine care of clinic or health center and use drugs if necessary
Eligibility Criteria
You may qualify if:
- systolic blood pressure ≥ 135mmHg or
- diastolic blood pressure ≥ 85mmHg
- absence of severe preeclampsia condition
- eclampsia
- absence chronic hypertension
- gestational age 20-36w
- single pregnancy
- have not contraction or bleeding
- absence of underlying disease and mental disorders
- absence of polihydramnios
- hydatiform mole and placenta previa
- not addicted to drugs, alcohol, mood-altering medicine and cigarette
- not to use similar relaxation methods and breathing techniques during pregnancy
- reading and writing literacy
- have contact number
You may not qualify if:
- using antihypertensive drugs(for experimental groups)
- CBR
- bleeding
- contraction or watering during study
- deteriorating of preeclampsia to severe form
- hospitalization
- start medical treatment for experiment groups
- changing mind for continuing with study
- to be absent in one session of personal instruction for experiment groups do not exercises more than 3 sessions of relaxation and breathing control at home
- delivery during 4- week interventions and presence of symptoms such as confusion, fatigue, feeling of suffocation, pain, blurred vision during doing exercises
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- researcher
Study Record Dates
First Submitted
July 24, 2012
First Posted
August 15, 2012
Study Start
February 1, 2010
Primary Completion
September 1, 2011
Study Completion
February 1, 2012
Last Updated
August 16, 2012
Record last verified: 2012-08